Clinical trial
Using the Superb Microvascular Imaging Method in the Diagnosis of Intraocular Tumors (SMITIS)
NCT05051384 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using the Superb Microvascular Imaging Method in the Diagnosis of Intraocular Tumors (SMITIS)
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 27, 2022
- Completion date
- January 18, 2026
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ocular tumor